ASP Isotopes Inc. Files 8-K Report
Ticker: ASPI · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1921865
Sentiment: neutral
Topics: disclosure, financials
TL;DR
ASP Isotopes filed an 8-K on Nov 12, 2025, for disclosures and financials.
AI Summary
On November 12, 2025, ASP Isotopes Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the submission of Financial Statements and Exhibits. The company, incorporated in Delaware with EIN 87-2618235, is located at 601 Pennsylvania Avenue NW, Washington, DC. The report was filed as of November 12, 2025.
Why It Matters
This 8-K filing indicates that ASP Isotopes Inc. is providing updated disclosures and financial information to the SEC, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- ASP Isotopes Inc. (company) — Registrant
- November 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 87-2618235 (identifier) — IRS Employer Identification No.
- 601 Pennsylvania Avenue NW, South Building, Suite 900 Washington, DC 20004 (address) — Principal executive offices
- 202-756-2245 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for ASP Isotopes Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date was this 8-K report filed or deemed filed?
The report was filed as of November 12, 2025.
In which state is ASP Isotopes Inc. incorporated?
ASP Isotopes Inc. is incorporated in Delaware.
What is the business address of ASP Isotopes Inc.?
The business address is 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, DC 20004.
What is the IRS Employer Identification Number for ASP Isotopes Inc.?
The IRS Employer Identification Number is 87-2618235.
Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2025-11-12 16:31:19
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC
Filing Documents
- aspi_8k.htm (8-K) — 28KB
- aspi_ex991.htm (EX-99.1) — 5KB
- aspi_ex991img3.jpg (GRAPHIC) — 3KB
- aspi_ex991img4.jpg (GRAPHIC) — 3KB
- 0001477932-25-008096.txt ( ) — 163KB
- aspi-20251112.xsd (EX-101.SCH) — 5KB
- aspi-20251112_lab.xml (EX-101.LAB) — 15KB
- aspi-20251112_cal.xml (EX-101.CAL) — 1KB
- aspi-20251112_pre.xml (EX-101.PRE) — 10KB
- aspi-20251112_def.xml (EX-101.DEF) — 2KB
- aspi_8k_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On November 12, 2025, ASP Isotopes Inc. (the "Company") issued a press release announcing that Quantum Leap Energy LLC ("QLE"), the Company's wholly-owned subsidiary, has confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission relating to the proposed initial public offering of QLE's Class A common stock. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. This Current Report on Form 8-K and the press release filed hereto as Exhibit 99.1 are being issued pursuant to, and in accordance with, Rule 135 promulgated under the Securities Act. This Current Report on Form 8-K and the press release filed hereto as Exhibit 99.1 do not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release, dated November 12, 2025. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: November 12, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 3